Compare GXAI & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GXAI | EVGN |
|---|---|---|
| Founded | 2021 | 1999 |
| Country | United States | Israel |
| Employees | 3 | N/A |
| Industry | | Agricultural Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 5.1M |
| IPO Year | 2022 | 2013 |
| Metric | GXAI | EVGN |
|---|---|---|
| Price | $0.40 | $0.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 119.5K | 39.2K |
| Earning Date | 11-20-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.35 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,933,030.00 | N/A |
| Revenue This Year | $462.16 | N/A |
| Revenue Next Year | $30.00 | $81.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 47901.74 | N/A |
| 52 Week Low | $0.41 | $0.35 |
| 52 Week High | $5.26 | $1.28 |
| Indicator | GXAI | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 37.21 | 21.66 |
| Support Level | N/A | N/A |
| Resistance Level | $0.52 | $0.41 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 27.02 | 7.95 |
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.